Xytos International Submits Prospectus for the Entry Standard Level of the Frankfurt Stock Exchange
(firmenpresse) - Xytos International Submits Prospectus for the Entry Standard Level of the Frankfurt Stock Exchange
Frankfurt, Germany -- (IR-World) – December 11, 2012 – XYTOS International, Inc. (the "Company") (Frankfurt Trading Symbol: XY5N) is pleased to announce that the company has completed its Prospectus which is required for uplifting the company to the Entry Standard Level of the Frankfurt Stock Exchange.
Since the announcement by the BaFin that the First Quotation Board would be closing, XYTOS International as worked for months preparing all documentation necessary to comply with the new rules and to move the company to the Entry Standard Level of the Frankfurt Stock Exchange. On November 30, 2012 at 4:01pm the XYTOS, prospectus was received by the BaFin.
XYTOS has been in business for over 9 Years and XYTOS exceeds all the Entry Standard requirements including Assets, Paid in Capital and Stock Price for inclusion in the Entry Standard.
Further, with a large majority of our key supporters based in Europe as well as a number of our Doctors and Medical Management it was an important step to complete the prospectus with the goal of moving to the Entry Standard. This major step forward will allow XYTOS to grow in Europe, which will allow the company to reach out and assist more patients.
Tim Cook, Chairman and CEO of XYTOS International, Inc., commented, “We at XYTOS are truly excited that we have completed the Prospectus necessary to move XYTOS to the Entry Standard Level of the Frankfurt Stock Exchange. The completion of the Prospectus is a significant step forward for XYTOS and this new level of transparency will open the door for many opportunities that the company is already working on”
XYTOS International is an Advanced Bio-Medical Technologies Company with the Mission to accelerate the future of the "Science of Medicine" and position itself as a Global Leader in the Research, Development, and Introduction of Advanced Medicine and Medical Procedures in the areas of Cancer, Stem Cell Therapies, Tissue Engineering and Cellular Medicine. The XYTOS ultimate goal is to offer our patients a better quality of life. Learn more about XYTOS at xytosinternational.de
On behalf of the Board of Directors of: XYTOS International, Inc. Tim Cook, CEO (Contact informationen(at)xytosinternational.de - aktionare(at)xytosinternational.de)
Telephone: +49 (0) 69 6 77 33 463
Leseranfragen:
XYTOS, Inc.
8888 Keystone Crossing Plaza
Indianapolis, Indiana 46240 USA
Tel.: + 702 421 5206
Investor Relations
investors(at)xytos.com
" alt="Southern Silver Completes Due Diligence and Plans Exploration at Cerro Las Minitas with Freeport-McMoRan Exploration CorporationDatum: 11.12.2012 - 11:10 Uhr
Sprache: Deutsch
News-ID 211421
Anzahl Zeichen: 2550
contact information:
Town:
Wien
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 161 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Xytos International Submits Prospectus for the Entry Standard Level of the Frankfurt Stock Exchange
"
steht unter der journalistisch-redaktionellen Verantwortung von
Xytos International Inc. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
